Form 4: Vita Coco Chief Sales Officer Executes Option Exercise and Share Sale Under 10b5-1 Plan

Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), exercised stock options and subsequently sold a portion of the acquired common stock on July 7, 2025, as part of a pre-arranged trading plan.

Summary

• Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), engaged in an equity transaction on July 7, 2025.
• Exercised 10,000 non-qualified stock options at an exercise price of $10.178 per share.
• Sold 10,000 shares of common stock at a weighted average price of $38.0178 per share, with individual transaction prices ranging from $38.00 to $38.05.
• The reported transactions were conducted pursuant to a Rule 10b5-1 trading plan.
• Following these transactions, Charles van Es directly beneficially owns 94,127 shares of common stock.
• Remaining derivative holdings include various non-qualified stock options with exercise prices ranging from $10.178 to $33.36, and varying vesting schedules and expiration dates.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The transaction is a routine insider equity management event, executed under a Rule 10b5-1 plan, which generally mitigates concerns about the timing of the sale. The significant profit realized by the executive from the option exercise is a positive for the individual, but the sale itself represents a reduction in direct insider ownership.

Positives

• The transaction was executed under a Rule 10b5-1 trading plan, indicating a pre-scheduled, non-discretionary sale, which often suggests personal financial planning rather than a reaction to new, undisclosed information.
• The sale price of $38.0178 per share is significantly higher than the exercise price of $10.178 per share, indicating a substantial realized gain for the Chief Sales Officer.

Negatives

• An insider selling shares, even under a pre-arranged plan, reduces their direct ownership stake in the company, which can sometimes be perceived neutrally to slightly negatively by the market.

Future Outlook

The document does not provide any forward-looking statements or guidance regarding the company's future performance, strategic direction, or financial estimates. It solely reports an insider's equity transaction.

Industry Context

This Form 4 filing is a routine disclosure of an insider's equity transaction and does not provide information directly related to broader industry trends or the competitive landscape within the beverage sector. It reflects an individual executive's personal financial planning and compensation management rather than a corporate strategic move or operational update.

Comparison to Industry Standards

• This document reports an insider transaction, which is a standard disclosure requirement for publicly traded companies across all industries, including the beverage sector.
• It does not contain financial results, operational metrics, or strategic initiatives that would allow for a direct comparison to industry benchmarks or specific comparable companies such as PepsiCo, Coca-Cola, or Keurig Dr Pepper.
• The transaction itself, involving the exercise and subsequent sale of stock options, is a common practice for executives managing their equity compensation and is consistent with typical insider trading activities observed across the market.

Stakeholder Impact

• Shareholders: The sale by a key officer, even under a 10b5-1 plan, slightly reduces insider ownership, which some investors might monitor. However, the pre-planned nature typically lessens any negative interpretation.
• Employees: No direct impact on employees is indicated by this transaction report.
• Customers: No direct impact on customers is indicated by this transaction report.
• Suppliers: No direct impact on suppliers is indicated by this transaction report.
• Creditors: No direct impact on creditors is indicated by this transaction report.

Key Dates

Keywords

Vita Coco Company, COCO, SEC Form 4, Insider Trading, Stock Options, Rule 10b5-1, Charles van Es, Chief Sales Officer, Equity Transaction, Beneficial Ownership